Apheresis Market is Expected to Grow at CAGR of 8.90% during forecast period 2023-2030

Market Highlights

The Apheresis market is expected to reach USD 1.99 billion by 2030 at 8.90% CAGR during the forecast period 2022-2030. Apheresis is the procedures for the separation and purification of the blood. These procedure are been performed since 1950’s for the treatment of various neurological, renal, hematological, autoimmune and other diseases. According to National Kidney Foundation, 10% of the population across the globe is suffering from chronic renal diseases and millions of people dies every year due to unaffordable treatment. Increasing demand for the plasma and platelets for the treatment of huge patient population, continuous development in technology and increasing need of automated and advanced devices has driven the global apheresis market

Beside this increasing number of accidents and rising prevalence of diseases has also contributed in the growth of the market. On other hand, lack of skilled professional and high cost of procedures has limit the growth of the market.

Segmentation:

Global apheresis market is segmented on the basis of product into devices and disposables. Devices are further segmented into plasma separators, platelets separators and other. On the basis of procedures they are plateletpheresis, leukapheresis, erythrocytapheresis, plasmapheresis and other. On the basis of methods they are centrifugation and filtration. Centrifugation is further segmented into continuous flow centrifugation, intermittent flow centrifugation and other. On the basis of application the market is segmented into oncological diseases, renal diseases, cardiovascular diseases, haematological diseases, immunological diseases, neurological diseases and other and on the basis of end user they are blood banks, hospitals and other.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Apheresis Market Research Report

Key Players

The major key player for the global apheresis market are Asahi Kasei Medical Co. Ltd. (Japan), Fresenius Medical Care (Germany), Terumo BCT, Inc. (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), HemaCare Corporation (US), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan), Cerus Corporation (US), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), Therakos, Inc. (US).

Global apheresis market is oligopolistic in nature and top 5 company shares more than 80% of the market share. Companies are focusing on the new product developments which will be cost effective. Some major competitors have adopted strategies of acquisitions and strategic alliances for the growth of the market.

Haemonetics Corporation is one of the leading global provider of blood and plasma supplies and services headquartered in US. MCS+ 9000 and PCS 2 are major platelets and plasma collecting system respectively. MCS 8150 device has been recognized as the standard in red cell collection. Haemonetics Corporation 4th quarter fiscal year 2016 earnings was $243.2 million which is increased by 10% compared to the fourth quarter of fiscal 2015. This company hold approximately 35% of total.